Answers are grounded in this paper and cite their sources.
Very high levels of vWF and factor VIIIc are common in COVID-19 patients, comparable to levels in severely septic non-COVID ICU patients. This could contribute to the hypercoagulable state and increased VTE rate in COVID-19. Further studies are needed to evaluate the use of vWF for stratifying thrombotic risk in COVID-19 and to determine if elevated vWF is contributing to disease pathogenesis.
No takes yet. Share an insight, caveat, or question.
Ladikou et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: